Label: ADVANCED CERAMIDE LIFT AND FIRM DAY CREAM BROAD SPECTRUM SUNSCREEN SPF 15- octisalate, octocrylene, avobenzone, homosalate emulsion

  • NDC Code(s): 10967-689-17, 10967-689-60, 10967-689-61, 10967-689-64
  • Packager: REVLON
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 31, 2024

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENTS

    AVOBENZONE 3.00%

    HOMOSALATE 10.0%

    OCTISALATE 5.0%

    OCTOCRYLENE 8.0%

  • OTHER INGREDIENTS

    WATER/AQUA/EAU, GLYCERIN, HEXYLENE GLYCOL, DIMETHICONE, C14-22 ALCOHOLS, PEG-100 STEARATE, GLYCERYL STEARATE, STYRENE/ACRYLATES COPOLYMER, ACRYLATES/DIMETHICONE COPOLYMER, POLYMETHYLSILSESQUIXANE, ACETYL TETRAPEPTIDE-11, ACETYL TETRAPEPTIDE-9, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, AMMONIUM HYDROXIDE, BUTYLENE GLYCOL, C12-20 ALKYL GLUCOSIDE, CAPRYLYL GLYCOL, CARBOMER, CERAMIDE AP, CERAMIDE EOP, CERAMIDE NP, CHOLESTEROL, DIMETHYL ISOSORBIDE, DISODIUM EDTA, ETHLYHEXYL PALMITATE, HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL, TAURATE COPOLYMER, ISOHEXADECANE, LEONTOPODIUM ALPINUM CALLUS CULTURE EXTRACT, MARIS SAL/SEA SALT/SEL MARIN, PHYTOSPHINGOSINE, POLYSORBATE 20, POLYSORBATE 60, SILICA DIMETHYL SILYLATE, SODIUM CARRAGEENAN, SODIUM HYALURONATE, SODIUM LAUROYL LACTYLATE, TOCOPHERYL ACETATE, TROMETHAMINE, XANTHAM GUM, FRAGRANCE, CHLORPHENESIN, PHENOXYETHANOL.

  • USES

    • Helps prevent sunburn
    • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
  • WARNINGS

    • For external use only
    • Do not use on damaged or broken skin
    • When using this product keep out of eyes. Rinse with water to remove.
    • Stop use and ask a doctor if rash occurs
    • keep out of reach of children.

    If product is swallowed, get medical help or contact a Poison Control Center right away.

  • DIRECTIONS

    • Apply liberally 15 minutes before sun exposure
    • Reapply:

    - at least every 2 hours

    • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:

    - Limit time in the sun, especially from 10 a.m. - 2 p.m.

    - Wear long-sleeve shirts, pants, hats, and sunglasses

    • Use a water resistant sunscreen if swimming or sweating
    • Children under 6 months: Ask a doctor.
  • DOSAGE & ADMINISTRATION

    Apply liberally 15 minutes before sun exposure.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of the reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

  • PURPOSE

    Sunscreen

  • INDICATIONS & USAGE

    Helps prevent sunbunrs. If used as directed with other sun protection measures (See Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

  • CARTON ART

    15 mL Tube

  • INGREDIENTS AND APPEARANCE
    ADVANCED CERAMIDE LIFT AND FIRM DAY CREAM  BROAD SPECTRUM SUNSCREEN SPF 15
    octisalate, octocrylene, avobenzone, homosalate emulsion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10967-689
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE100 mg  in 1 g
    OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE80 mg  in 1 g
    AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE30 mg  in 1 g
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE50 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
    ACETYL TETRAPEPTIDE-9 (UNII: VMO8OOD3V0)  
    LEONTOPODIUM NIVALE SUBSP. ALPINUM WHOLE (UNII: 99S85B4VEB)  
    ACETYL TETRAPEPTIDE-11 (UNII: 0R3VC3BV8I)  
    CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
    HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
    ETHYLHEXYL PALMITATE (UNII: 2865993309)  
    CERAMIDE NP (UNII: 4370DF050B)  
    WATER (UNII: 059QF0KO0R)  
    TROMETHAMINE (UNII: 023C2WHX2V)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    CHOLESTEROL (UNII: 97C5T2UQ7J)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PEG-100 STEARATE (UNII: YD01N1999R)  
    EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    CHLORPHENESIN (UNII: I670DAL4SZ)  
    SEA SALT (UNII: 87GE52P74G)  
    POLYSORBATE 60 (UNII: CAL22UVI4M)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    CERAMIDE AP (UNII: F1X8L2B00J)  
    STYRENE/ACRYLAMIDE COPOLYMER (MW 500000) (UNII: 5Z4DPO246A)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    C12-20 ALKYL GLUCOSIDE (UNII: K67N5Z1RUA)  
    DIMETHYL ISOSORBIDE (UNII: SA6A6V432S)  
    2-ETHYLHEXYL ACRYLATE, METHACRYLATE, METHYL METHACRYLATE, OR BUTYL METHACRYLATE/HYDROXYPROPYL DIMETHICONE COPOLYMER (30000-300000 MW) (UNII: S7ZA3CCJ4M)  
    SILICA DIMETHYL SILYLATE (UNII: EU2PSP0G0W)  
    C14-22 ALCOHOLS (UNII: B1K89384RJ)  
    HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)  
    ISOHEXADECANE (UNII: 918X1OUF1E)  
    SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO)  
    CERAMIDE 1 (UNII: 5THT33P7X7)  
    ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    CARRAGEENAN SODIUM (UNII: 7CY8BVL34N)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:10967-689-6115 g in 1 TUBE; Type 0: Not a Combination Product08/01/2021
    2NDC:10967-689-645 g in 1 TUBE; Type 0: Not a Combination Product08/01/2021
    3NDC:10967-689-1750 g in 1 JAR; Type 0: Not a Combination Product08/01/2021
    4NDC:10967-689-602 g in 1 PACKET; Type 0: Not a Combination Product08/01/2021
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02008/01/2021
    Labeler - REVLON (788820165)
    Registrant - REVLON (788820165)
    Establishment
    NameAddressID/FEIBusiness Operations
    REVLON, INC.809725570manufacture(10967-689)